BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29985978)

  • 1. Randomized Trial of Community Treatment With Azithromycin and Ivermectin Mass Drug Administration for Control of Scabies and Impetigo.
    Marks M; Toloka H; Baker C; Kositz C; Asugeni J; Puiahi E; Asugeni R; Azzopardi K; Diau J; Kaldor JM; Romani L; Redman-MacLaren M; MacLaren D; Solomon AW; Mabey DCW; Steer AC
    Clin Infect Dis; 2019 Mar; 68(6):927-933. PubMed ID: 29985978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial.
    Romani L; Marks M; Sokana O; Nasi T; Kamoriki B; Cordell B; Wand H; Whitfeld MJ; Engelman D; Solomon AW; Kaldor JM; Steer AC
    Lancet Infect Dis; 2019 May; 19(5):510-518. PubMed ID: 30956111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of scabies in a tribal community using mass screening and treatment with oral ivermectin -A cluster randomized controlled trial in Gadchiroli, India.
    Behera P; Munshi H; Kalkonde Y; Deshmukh M; Bang A
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009330. PubMed ID: 33861741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Scabies and Impetigo 3 Years After Mass Drug Administration With Ivermectin and Azithromycin.
    Marks M; Romani L; Sokana O; Neko L; Harrington R; Nasi T; Wand H; Whitfeld MJ; Engelman D; Solomon AW; Kaldor JM; Steer AC
    Clin Infect Dis; 2020 Apr; 70(8):1591-1595. PubMed ID: 31131410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial.
    Romani L; Marks M; Sokana O; Nasi T; Kamoriki B; Wand H; Whitfeld MJ; Engelman D; Solomon AW; Steer AC; Kaldor JM
    Lancet Glob Health; 2018 Oct; 6(10):e1132-e1138. PubMed ID: 30223985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One versus two doses of ivermectin-based mass drug administration for the control of scabies: A cluster randomised non-inferiority trial.
    Lake SJ; Engelman D; Zinihite J; Sokana O; Boara D; Nasi T; Gorae C; Osti MH; Phelan S; Parnaby M; Grobler AC; Schuster T; Andrews R; Whitfeld MJ; Marks M; Romani L; Steer AC; Kaldor JM
    PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011207. PubMed ID: 36930667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass Drug Administration for Scabies - 2 Years of Follow-up.
    Romani L; Whitfeld MJ; Koroivueta J; Kama M; Wand H; Tikoduadua L; Tuicakau M; Koroi A; Andrews RM; Kaldor JM; Steer AC
    N Engl J Med; 2019 Jul; 381(2):186-187. PubMed ID: 31242358
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of ivermectin, diethylcarbamazine citrate, and albendazole mass drug administration on the prevalence of scabies and soil-transmitted helminths in school-aged children in three municipalities in Timor-Leste: a before-after assessment.
    Le B; Monteiro MAA; Amaral S; Wand H; Matthews A; Hii SF; Clarke NE; Arkell P; Yan J; Engelman D; Fancourt N; Fernandes JL; Steer A; Kaldor J; Traub R; Francis JR; Nery SV
    Lancet Glob Health; 2023 Jun; 11(6):e924-e932. PubMed ID: 37202027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Drug Administration for the Control of Scabies: A Systematic Review and Meta-analysis.
    Lake SJ; Kaldor JM; Hardy M; Engelman D; Steer AC; Romani L
    Clin Infect Dis; 2022 Sep; 75(6):959-967. PubMed ID: 35088849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass Drug Administration for Scabies Control in a Population with Endemic Disease.
    Romani L; Whitfeld MJ; Koroivueta J; Kama M; Wand H; Tikoduadua L; Tuicakau M; Koroi A; Andrews R; Kaldor JM; Steer AC
    N Engl J Med; 2015 Dec; 373(24):2305-13. PubMed ID: 26650152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study).
    Lake SJ; Phelan SL; Engelman D; Sokana O; Nasi T; Boara D; Gorae C; Schuster T; Grobler AC; Osti MH; Andrews R; Marks M; Whitfeld MJ; Romani L; Kaldor J; Steer A
    BMJ Open; 2020 Aug; 10(8):e037305. PubMed ID: 32868360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community control strategies for scabies: A cluster randomised noninferiority trial.
    Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Schuster T; Grobler AC; Engelman D; Robinson LJ; Kaldor JM; Steer AC
    PLoS Med; 2021 Nov; 18(11):e1003849. PubMed ID: 34758017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Term Control of Scabies Fifteen Years after an Intensive Treatment Programme.
    Marks M; Taotao-Wini B; Satorara L; Engelman D; Nasi T; Mabey DC; Steer AC
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004246. PubMed ID: 26624616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ivermectin administered for scabies treatment on the prevalence of head lice in Atoifi, Solomon Islands.
    Coscione S; Esau T; Kekeubata E; Diau J; Asugeni R; MacLaren D; Steer AC; Kositz C; Marks M
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006825. PubMed ID: 30252856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control.
    Bojang E; Jafali J; Perreten V; Hart J; Harding-Esch EM; Sillah A; Mabey DC; Holland MJ; Bailey RL; Roca A; Burr SE
    BMC Microbiol; 2017 Mar; 17(1):75. PubMed ID: 28351345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass drug administration campaigns for scabies and impetigo: protocol for a systematic review and meta-analysis.
    Ghosh P; Tesfaye W; Manandhar A; Calma T; Bushell M; Oguoma VM; Kosari S; McMillan F; Peterson G; Thomas J
    BMJ Paediatr Open; 2021; 5(1):e001132. PubMed ID: 34263086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of scabies and impetigo in school-age children in Timor-Leste.
    Matthews A; Le B; Amaral S; Arkell P; Monteiro M; Clarke N; Barros T; de Jesus Mendonça J; Gusmão SME; Dos Reis Seixas LM; da Piedade JHA; Engelman D; Steer AC; Fancourt NSS; Yan J; Kaldor J; Francis JR; Nery SV
    Parasit Vectors; 2021 Mar; 14(1):156. PubMed ID: 33722285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis--a rapid assessment methodology to assess impact.
    Mohammed KA; Deb RM; Stanton MC; Molyneux DH
    Parasit Vectors; 2012 Dec; 5():299. PubMed ID: 23259465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community perspectives on scabies, impetigo and mass drug administration in Fiji: A qualitative study.
    Mitchell E; Bell S; Thean LJ; Sahukhan A; Kama M; Koroivueti A; Kaldor J; Steer A; Romani L
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008825. PubMed ID: 33275592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epidemiology of Scabies and Impetigo in Relation to Demographic and Residential Characteristics: Baseline Findings from the Skin Health Intervention Fiji Trial.
    Romani L; Whitfeld MJ; Koroivueta J; Kama M; Wand H; Tikoduadua L; Tuicakau M; Koroi A; Ritova R; Andrews R; Kaldor JM; Steer AC
    Am J Trop Med Hyg; 2017 Sep; 97(3):845-850. PubMed ID: 28722612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.